phenylalanine and sulfaphenazole

phenylalanine has been researched along with sulfaphenazole in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fisher, MB; Haining, RL; Henne, KR; Jones, JP; Koop, DR; Rettie, AE; Trager, WF	1
Assrir, N; Dansette, PM; Jaouen, M; Jean, P; Mansuy, D; Marques-Soares, C; Melet, A; Pilar Lopez-Garcia, M; Sari, MA	1

Other Studies

2 other study(ies) available for phenylalanine and sulfaphenazole

Article	Year
Enzymatic determinants of the substrate specificity of CYP2C9: role of B'-C loop residues in providing the pi-stacking anchor site for warfarin binding. Biochemistry, 1999, Mar-16, Volume: 38, Issue:11 Topics: Arachidonic Acid; Aryl Hydrocarbon Hydroxylases; Binding Sites; Blotting, Western; Catalysis; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diclofenac; Kinetics; Lauric Acids; Leucine; Mutagenesis, Site-Directed; Phenylalanine; Protein Structure, Secondary; Static Electricity; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Substrate Specificity; Sulfaphenazole; Warfarin	1999
Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid. Archives of biochemistry and biophysics, 2003, Jan-01, Volume: 409, Issue:1 Topics: Amino Acids; Anti-Infective Agents; Aryl Hydrocarbon Hydroxylases; Binding Sites; Crystallography, X-Ray; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2C9; Diclofenac; Humans; Kinetics; Microsomes; Models, Chemical; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Phenylalanine; Protein Binding; Protein Structure, Tertiary; Software; Spectrophotometry; Substrate Specificity; Sulfaphenazole; Ticrynafen; Time Factors; Ultraviolet Rays; Yeasts	2003

Article

Year

Enzymatic determinants of the substrate specificity of CYP2C9: role of B'-C loop residues in providing the pi-stacking anchor site for warfarin binding.

Biochemistry, 1999, Mar-16, Volume: 38, Issue:11

Topics: Arachidonic Acid; Aryl Hydrocarbon Hydroxylases; Binding Sites; Blotting, Western; Catalysis; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diclofenac; Kinetics; Lauric Acids; Leucine; Mutagenesis, Site-Directed; Phenylalanine; Protein Structure, Secondary; Static Electricity; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Substrate Specificity; Sulfaphenazole; Warfarin

1999

Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid.

Archives of biochemistry and biophysics, 2003, Jan-01, Volume: 409, Issue:1

Topics: Amino Acids; Anti-Infective Agents; Aryl Hydrocarbon Hydroxylases; Binding Sites; Crystallography, X-Ray; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2C9; Diclofenac; Humans; Kinetics; Microsomes; Models, Chemical; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Phenylalanine; Protein Binding; Protein Structure, Tertiary; Software; Spectrophotometry; Substrate Specificity; Sulfaphenazole; Ticrynafen; Time Factors; Ultraviolet Rays; Yeasts

2003